Global Retinoid Market Poised for Growth, Expected to Reach US$ 3.05 Billion by 2034 at a moderate CAGR of 6.5% | Future Market Insights

The global retinoid market will follow the growth path to reach US$ 3.05 billion by 2034. Moreover, it will reach US$ 1.63 billion by 2024. This advancement will likely occur at a moderate CAGR of 6.5%.

The fundamental retinoid demand generator is the rising demand for preventive treatments. More patients have started to emphasize preventive treatment to avoid exponential medical bills and excessive health damage due to lack of attention. This spurs the demand for retinoids from retinoid manufacturers and suppliers, driving the market.

Get Access to Sample Now:

Minimal-invasive treatments have been used recently. Medical professionals focus on tablets, moisturizers, lotions, and other non-invasive therapies to avoid complications. Therefore, this surges the demand for retinoids.

The increasing hair loss and damage cases increase the need for retinoids to restore damaged physical health. Other skincare related diseases also spur the need for retinoids, driving the market.

Key Takeaways from the Market Study:

  • The Russian market, due to its extreme weather conditions, provides the highest growth opportunities for the retinoid market. It is estimated to propel at a CAGR of 13.3%, the highest.
  • The French cosmetic industry is attributed to the impressive retinoid market growth in the global market. It is anticipated to leap at a CAGR of 8.4% through 2034.
  • The rising prevalence of acne cases in young adults in Latin America, the growth opportunities are rising in the region. Brazil estimates a CAGR of 5.8%.
  • Synthetic retinoids, due to their wide applicability, are used the maximum, ensuring they will occupy 77.3% of market space by 2024.

“Due to the side effects of retinoids, alternative therapies and treatments are growing, affecting the growth opportunities of the subject market. This is a key market challenge,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Request Customization of the Report:

Competitive Landscape of the Retinoid Market:

Several multi-national medical institutions and organizations clutter the healthcare sector. Due to this, the industry experiences a great competitive force. Organizations strive to expand in the industry using strategic initiatives like partnerships, collaboration, and international expansion.

The following key developments have recently occurred in the market:-

  • In September 2019, Mylan Pharmaceuticals Inc. and Eisai India entered a collaboration agreement that focused on commercializing Teceris, the second Eribulin Brand in India. This strategic initiative has helped the organization in bolstering its international position.
  • In October 2023, GlaxoSmithKline Inc. partnered with Zhifei to produce vaccines in China. The latter will receive all rights to import and distribute vaccines of the organization in China. This will mark the presence of the organization in the international market.

Report Scope Retinoid Market:

Attributes Details
Estimated Market Size in 2024 US$ 1.63 billion
Projected Market Valuation in 2034 US$ 3.05 billion
Value-based CAGR 2024 to 2034 6.5%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis Value in US$ billion
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa
Key Market Segments Covered
  • Type
  • Application
  • Distribution Channel
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • Poland
  • Russia
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC Countries
  • South Africa
  • Israel
Key Companies Profiled
  • GlaxoSmithKline Inc.
  • Mylan Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Ortho Dermatologics

Get Complete Full Report:

Retinoid Market- Key Segments

By Type:

  • Natural Retinoids
  • Synthetic Retinoids

By Application:

  • Acne
  • Psoriasis
  • Anti-aging
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Supermarkets / Hypermarkets

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

Moderate-to-Severe Acne Treatment Market Size: The global moderate-to-severe acne treatment market was valued at US$ 1.2 Billion in 2022 and is expected to reach US$ 2.4 Billion by 2033. The retinoid therapy with around 25.6% value share, has topped the global market within the treatment category in 2022 and is expected to grow at a CAGR of close to 6.5% over the forecast period (2023 to 2033).

Skincare Market Share: The global skincare market size is estimated to be US$ 1,66,870.4 million in 2024. The skincare product sales are expected to witness a robust CAGR of 8.6% from 2024 to 2034. By 2034, the skincare product demand is anticipated to achieve a valuation of US$ 3,80,492.2 million.

Men’s Skincare Products Market Demand: The men’s skincare products market is estimated to be valued at US$ 15,078.23 million in 2023 and is expected to total US$ 37,000 million by 2033. The adoption of men’s skincare products is likely to advance at a CAGR of 9.4% during the forecast period.

Biologic Excipient Market Growth: The global biologic excipient market is projected to be appraised at US$ 2,241.8 million by 2034, up from US$ 1500 million in 2024, advancing at a CAGR of 4.10% from 2024 to 2034.

Pharmaceutical Excipient Market Trends: According to updated research, the pharmaceutical excipient market is set to hold a valuation of US$ 972.9 million in 2024. Thereafter, the market’s progress over the coming decade is suggested to be solid, with a CAGR of 5.1%. As such, the market’s value by 2034 is marked to jump to US$ 1,600.0 million.

Electronic Stethoscope Market Outlook: According to the recently upgraded market intelligence report by FMI, the electronic stethoscope market is predicted to be valued at US$ 292.2 million in 2024. By the end of 2034, the market is estimated to achieve US$ 528.2 million and is slated to expand at a 6.10% CAGR in the following decade.

Pharmacy Automation System Market Overview: The pharmacy automation system market is on a continuum to register a CAGR of 8.00% from 2024 to 2034. The market is set to reach US$ 5,621.5 million in 2024. Considering the market analysis and growing trend throughout, the market valuation is very likely to surpass US$ 12,136.3 million by 2034.

Immunomodulator Market Opportunity: global immunomodulator market size will reach US$ 88.6 billion in 2024, Development of more effective and safe immunotherapies will further boost sales growth, resulting in total market valuation reaching a staggering US$ 178.0 billion by 2034. Global immunomodulator demand is forecast to surge at 7.2% CAGR throughout the forecast period.

Medical Mask Market Strategies: In 2024, the medical mask market size amounts to US$ 6,017.30 million and is probable to reach US$ 16,780.20 million by 2034, increase at a CAGR of 10.80%.

Respiratory Device Market Development: Respiratory Device Market valuation to an astounding US$ 26873.7 million in 2024, as the industry analysis exhibits an outstanding growth of 9.90% CAGR through 2034, the market valuation is very likely to surpass US$ 69,072.5 million by the end of 2034.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Matched content

Editor’s pick

Express Press Release Distribution